Randers Regional Hospital   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Randers Denmark (1954)

Organization Overview

First Clinical Trial
2014
NCT01969006
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Randers Regional Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

oxytocin (syntocinon) (1 trial)

Drugs in Phase 2 Trials (3)

crystalloid (1 trial)

levobupivacaine (chirocaine) (1 trial)

pembrolizumab (keytruda) (1 trial)

Drugs in Other Trials (1)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5